IS6183A - Díamínóþíazol og notagildi þeirra til að hindra prótín kínasa - Google Patents

Díamínóþíazol og notagildi þeirra til að hindra prótín kínasa

Info

Publication number: IS6183A
Authority: IS; Iceland
Prior art keywords: diaminothiazole; utility; protein kinase; inhibiting protein; inhibiting
Prior art date: 1999-06-04

Application number

IS6183A

Other languages

English (en)

Inventor

Song Shu Shao

Andrew Alegria Larry

Lee Bender Steven

Pritchett Benedict Suzanne

J. Borchardt Allen

Steven Kania Robert

David Nambu Mitchell

Marie Tempczyk-Russell Anna

Sarshar Sepehr

Bhumralkar Dilip

Peng Zhengwei

Michelle Yang Yi

Original Assignee

Agouron Pharmaceuticals, Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-06-04

Filing date

2001-11-29

Publication date

2001-11-29

2001-11-29 Application filed by Agouron Pharmaceuticals, Inc. filed Critical Agouron Pharmaceuticals, Inc.

2001-11-29 Publication of IS6183A publication Critical patent/IS6183A/is

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
- C07F9/6539—Five-membered rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Thiazole And Isothizaole Compounds (AREA)

IS6183A 1999-06-04 2001-11-29 Díamínóþíazol og notagildi þeirra til að hindra prótín kínasa IS6183A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US13781099P	1999-06-04	1999-06-04
PCT/US2000/015188 WO2000075120A1 (en)	1999-06-04	2000-06-02	Diaminothiazoles and their use for inhibiting protein kinases

Publications (1)

Publication Number	Publication Date
IS6183A true IS6183A (is)	2001-11-29

Family

ID=22479135

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS6183A IS6183A (is)	1999-06-04	2001-11-29	Díamínóþíazol og notagildi þeirra til að hindra prótín kínasa

Country Status (34)

Country	Link
US (1)	US6620828B2 (is)
EP (1)	EP1181283B1 (is)
JP (1)	JP2003501420A (is)
KR (1)	KR20020015333A (is)
CN (1)	CN1359380A (is)
AP (1)	AP2001002341A0 (is)
AT (1)	ATE288424T1 (is)
AU (1)	AU778071B2 (is)
BG (1)	BG106276A (is)
BR (1)	BR0011585A (is)
CA (1)	CA2371158A1 (is)
CZ (1)	CZ20014213A3 (is)
DE (1)	DE60017894T2 (is)
EA (1)	EA200101268A1 (is)
EE (1)	EE200100659A (is)
ES (1)	ES2234628T3 (is)
HR (1)	HRP20020008A2 (is)
HU (1)	HUP0202897A3 (is)
IL (1)	IL146094A0 (is)
IS (1)	IS6183A (is)
MA (1)	MA25530A1 (is)
MX (1)	MXPA01012483A (is)
NO (1)	NO20015045L (is)
NZ (1)	NZ514881A (is)
OA (1)	OA11959A (is)
PE (1)	PE20010211A1 (is)
PL (1)	PL352714A1 (is)
SK (1)	SK17302001A3 (is)
SV (1)	SV2002000096A (is)
UA (1)	UA71971C2 (is)
UY (1)	UY26190A1 (is)
WO (1)	WO2000075120A1 (is)
YU (1)	YU85601A (is)
ZA (1)	ZA200108291B (is)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20020150921A1 (en) *	1996-02-09	2002-10-17	Francis Barany	Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
US6569878B1 (en) *	1997-10-27	2003-05-27	Agouron Pharmaceuticals Inc.	Substituted 4-amino-thiazol-2-yl compounds as cyclin-dependent kinase inhibitors
US6262096B1 (en)	1997-11-12	2001-07-17	Bristol-Myers Squibb Company	Aminothiazole inhibitors of cyclin dependent kinases
US20040226056A1 (en) *	1998-12-22	2004-11-11	Myriad Genetics, Incorporated	Compositions and methods for treating neurological disorders and diseases
US7125875B2 (en)	1999-04-15	2006-10-24	Bristol-Myers Squibb Company	Cyclic protein tyrosine kinase inhibitors
PT1169038E (pt)	1999-04-15	2012-10-26	Bristol Myers Squibb Co	Inibidores cíclicos da proteína tirosina cinase
ES2257461T3 (es)	2000-12-21	2006-08-01	Bristol-Myers Squibb Company	Inhibidores de tiazolilo de tirosina quinasas de la familia tec.
US6756374B2 (en)	2001-01-22	2004-06-29	Hoffmann-La Roche Inc.	Diaminothiazoles having antiproliferative activity
UA76977C2 (en)	2001-03-02	2006-10-16	Icos Corp	Aryl- and heteroaryl substituted chk1 inhibitors and their use as radiosensitizers and chemosensitizers
KR20040004705A (ko) *	2001-06-08	2004-01-13	시토비아 인크.	카스파제의 활성제 및 아폽토시스의 유도제로서의 치환된3-아릴-5-아릴-[1,2,4]-옥사디아졸과 유사체 및 이의 용도
CA2474322A1 (en) *	2002-01-25	2003-07-31	Kylix Pharmaceuticals B.V.	4(hetero-) aryl substituted (thia-/oxa-/pyra) zoles for inhibition of tie-2
US6818663B2 (en) *	2002-05-17	2004-11-16	Hoffmann-La Roches	Diaminothiazoles
MXPA05001277A (es)	2002-08-02	2005-10-06	Ab Science	2-(3-aminoaril)amino-4-aril-tiazoles y su uso como inhibidores del c-kit.
US8450302B2 (en)	2002-08-02	2013-05-28	Ab Science	2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
PL376733A1 (pl) *	2002-11-01	2006-01-09	Takeda Pharmaceutical Company Limited	Środek do zapobiegania lub leczenia neuropatii
EP1597256A1 (en) *	2003-02-21	2005-11-23	Pfizer Inc.	N-heterocyclyl-substituted amino-thiazole derivatives as protein kinase inhibitors
US7078419B2 (en)	2003-03-10	2006-07-18	Boehringer Ingelheim Pharmaceuticals, Inc.	Cytokine inhibitors
EP3345895B1 (en)	2003-04-11	2019-12-04	PTC Therapeutics, Inc.	1,2,4-oxadiazole benzoic acid compound and its use for nonsense suppression and the treatment of disease
WO2004092217A1 (en) *	2003-04-17	2004-10-28	Pfizer Inc.	Crystal structure of vegfrkd: ligand complexes and methods of use thereof
EP1644323B1 (en) *	2003-07-07	2015-03-18	Georgetown University	Histone deacetylase inhibitors and methods of use thereof
CA2536954C (en)	2003-08-29	2012-11-27	Exelixis, Inc.	C-kit modulators and methods of use
SI1680140T1 (sl) *	2003-10-16	2011-08-31	Imclone Llc	Inhibitorji receptorja-1 za fibroblastni rastni faktor in metode za zdravljenje z le-temi
AU2005205201B2 (en) *	2004-01-12	2011-05-12	Merck Serono Sa	Thiazole derivatives and use thereof
WO2005108370A1 (ja) *	2004-04-16	2005-11-17	Ajinomoto Co., Inc.	ベンゼン化合物
US7211576B2 (en)	2004-04-20	2007-05-01	Hoffmann-La Roche Inc.	Diaminothiazoles
WO2006017216A1 (en) *	2004-07-12	2006-02-16	Merck & Co., Inc.	Histone deacetylase inhibitors
BRPI0611029A2 (pt)	2005-05-24	2010-08-10	Serono Lab	derivados de tiazol e uso dos mesmos
JP5290751B2 (ja) *	2005-05-24	2013-09-18	メルクセローノソシエテアノニム	チアゾール誘導体及びそれらの使用
ES2778846T3 (es)	2005-11-08	2020-08-12	Vertex Pharma	Moduladores heterocíclicos de transportadores de casete de unión a ATP
AU2012244242B2 (en) *	2005-12-28	2015-05-21	Vertex Pharmaceuticals Incorporated	1-(benzo [D] [1,3] dioxol-5-yl) -N- (phenyl) cyclopropane- carboxamide derivatives and related compounds as modulators of ATP-Binding Cassette transporters for the treatment of Cystic Fibrosis
AU2006336504C9 (en)	2005-12-28	2015-05-14	Vertex Pharmaceuticals Incorporated	1-(benzo [D] [1,3] dioxol-5-yl) -N- (phenyl) cyclopropane- carboxamide derivatives and related compounds as modulators of ATP-Binding Cassette transporters for the treatment of Cystic Fibrosis
EP1981884B1 (en) *	2006-01-18	2012-06-13	Amgen, Inc	Thiazole compounds as protein kinase b (pkb) inhibitors
JP2009526868A (ja) *	2006-02-15	2009-07-23	アボット・ラボラトリーズ	新規なアセチル−ＣｏＡカルボキシラーゼ（ＡＣＣ）阻害薬およびこれらの糖尿病、肥満および代謝症候群における使用
US8748627B2 (en) *	2006-02-15	2014-06-10	Abbvie Inc.	Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome
RU2462246C2 (ru)	2006-03-30	2012-09-27	ПиТиСи ТЕРАПЬЮТИКС, ИНК.	Способы получения функционального белка из днк, имеющей нонсенс-мутацию, и лечения нарушений, ассоциированных с ней
JP5153773B2 (ja) *	2006-07-07	2013-02-27	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	フェニル置換ヘテロアリール誘導体及び抗癌剤としてのその使用
WO2008080134A2 (en)	2006-12-22	2008-07-03	Rigel Pharmaceuticals, Inc.	4-amin0-2- (hetero) arylamino-5- (hetero) arylthiazoles useful as axl inhibitors
CN102863432B (zh)	2007-05-09	2016-09-07	沃泰克斯药物股份有限公司	Cftr调节剂
CL2008001943A1 (es)	2007-07-02	2009-09-11	Boehringer Ingelheim Int	Compuestos derivados de fenil-triazol, inhibidores de enzimas de señales especificas que participan del control de la proliferacion celular; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar cancer, infecciones, enfermedades inflamatorias y autoinmunes.
JP2010531850A (ja) *	2007-07-02	2010-09-30	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	新規化合物
WO2009011871A2 (en) *	2007-07-17	2009-01-22	Amgen Inc.	Thiadiazole modulators of pkb
WO2009011880A2 (en)	2007-07-17	2009-01-22	Amgen Inc.	Heterocyclic modulators of pkb
KR20150063170A (ko)	2007-12-07	2015-06-08	버텍스 파마슈티칼스 인코포레이티드	3-(6-(1-(2,2-디플루오로벤조[ｄ][1,3]디옥솔-5-일)사이클로프로판카복스아미도)-3-메틸피리딘-2-일)벤조산의 고체 형태
WO2009076142A2 (en)	2007-12-07	2009-06-18	Vertex Pharmaceuticals Incorporated	Processes for producing cycloalkylcarboxiamido-pyridine benzoic acids
WO2009076140A1 (en) *	2007-12-13	2009-06-18	Smithkline Beecham Corporation	Thiazole and oxazole kinase inhibitors
CN106432213A (zh)	2008-02-28	2017-02-22	沃泰克斯药物股份有限公司	作为cftr调节剂的杂芳基衍生物
UA103319C2 (en)	2008-05-06	2013-10-10	Глаксосмитклайн Ллк	Thiazole- and oxazole-benzene sulfonamide compounds
MX2011003292A (es)	2008-09-29	2011-04-21	Boehringer Ingelheim Int	Compuestos antiproliferativos.
PT2387395E (pt)	2009-01-16	2015-02-04	Rigel Pharmaceuticals Inc	Inibidores de axl para utilização em terapia de combinação para prevenir, tratar ou gerir cancro metastático
US8637557B2 (en)	2009-10-19	2014-01-28	Taisho Pharmaceutical Co., Ltd	Aminothiazole derivative
EP2552907B1 (en)	2010-03-26	2014-10-22	Boehringer Ingelheim International GmbH	Pyridyltriazoles
US9290507B2 (en)	2010-03-26	2016-03-22	Boehringer Ingelheim International Gmbh	B-RAF kinase inhibitors
BR112012026255A2 (pt)	2010-04-07	2017-03-14	Vertex Pharma	composições farmacêuticas de ácido 3-(6-(1-(2-,2-difluorbenzo[d][1,3]dioxol-5-il)ciclopropanocarboxamido)-3-metilpiridin-2-il)benzóico e administração das mesmas
US8710055B2 (en)	2010-12-21	2014-04-29	Boehringer Ingelheim International Gmbh	Triazolylphenyl sulfonamides as serine/threonine kinase inhibitors
DK2806859T3 (da)	2012-01-25	2019-08-05	Vertex Pharma	Formuleringer af 3-(6-(1-(2.2-difluorbenzo[d][1,3]dioxol-5-yl) cyclopropancarboxamido)-3-methylpyridin-2-yl)benzoesyre
EP2842955B1 (en)	2012-04-26	2016-10-05	ONO Pharmaceutical Co., Ltd.	Trk-inhibiting compound
HUE042591T2 (hu)	2013-02-19	2019-07-29	Ono Pharmaceutical Co	TRK-gátló vegyület
GB201309333D0 (en)	2013-05-23	2013-07-10	Agency Science Tech & Res	Purine diones as WNT pathway modulators
DK3068392T5 (da)	2013-11-12	2021-09-20	Vertex Pharma	Fremgangsmåde til fremstilling af farmaceutiske sammensætninger til behandlingen af cftr-medierede sygdomme
JP6946001B2 (ja)	2014-03-06	2021-10-06	ピーティーシーセラピューティクス，インコーポレイテッド	薬学的組成物、および１，２，４−オキサジアゾール安息香酸の塩
WO2016081556A1 (en)	2014-11-18	2016-05-26	Vertex Pharmaceuticals Incorporated	Process of conducting high throughput testing high performance liquid chromatography
HK1251965A1 (zh)	2015-10-30	2019-05-10	Ptc医疗公司	用於治疗癫痫的方法
CA3036245C (en) *	2016-09-13	2021-07-20	Arbutus Biopharma Corporation	Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same
CN111233786B (zh) *	2020-02-04	2021-11-26	中国人民解放军军事科学院军事医学研究院	含五元杂环的苯磺酰胺类化合物及其制备方法和用途
WO2025007859A1 (en) *	2023-07-03	2025-01-09	Insilico Medicine Ip Limited	Substituted thiazole compounds as cdk2/4/6 inhibitors and methods of use thereof
CN116874442B (zh) *	2023-07-27	2025-10-24	武汉呈瑞生物医药科技有限公司	一种有机化合物及其应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE273062C (de)	1912-04-19	1914-04-20	Deylen Sohn Firma	Vorrichtung zum Schränken von Plattenzündspänen
AU558132B2 (en)	1981-05-27	1987-01-22	Labatt Brewing Co. Ltd.	Malt sterilisation with hydrogen peroxide
US4994479A (en)	1985-04-03	1991-02-19	Yamanouchi Pharmaceutical Co., Ltd.	Phenylene derivatives and anti-allergic use thereof
AU658646B2 (en) *	1991-05-10	1995-04-27	Rhone-Poulenc Rorer International (Holdings) Inc.	Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
JPH07505155A (ja)	1992-03-24	1995-06-08	メルク　シヤープ　エンド　ドーム　リミテツド	コレシストキニン及び／又はガストリン拮抗活性を有する３−ウレイド置換ベンゾジアゼピン−２−オン及び治療におけるその使用
US5631156A (en)	1994-06-21	1997-05-20	The University Of Michigan	DNA encoding and 18 KD CDK6 inhibiting protein
KR970706813A (ko)	1994-11-10	1997-12-01	찰스 홈시	단백질 키나아제의 억제물질로서 유용한 제약용 피라졸 조성물(pharmaceutical pyrazole compositions useful as inhibitors of protein kinases)
BR9607016A (pt)	1995-02-02	1997-10-28	Smithkline Beecham Plc	Derivados de indol como antagonísta de receptor 5-ht
US5710173A (en)	1995-06-07	1998-01-20	Sugen, Inc.	Thienyl compounds for inhibition of cell proliferative disorders
WO1997003967A1 (en)	1995-07-22	1997-02-06	Rhone-Poulenc Rorer Limited	Substituted aromatic compounds and their pharmaceutical use
US5705499A (en)	1995-10-06	1998-01-06	Boehringer Ingelheim Pharmaceuticals, Inc.	8-arylalkyl- and 8-arylheteroalkyl-5,11-dihydro-6H-dipyrido 3,2-B:2',3'-e! 1!diazepines and their use in the treatment of HIV-1 infection
US5733920A (en)	1995-10-31	1998-03-31	Mitotix, Inc.	Inhibitors of cyclin dependent kinases
US5760028A (en)	1995-12-22	1998-06-02	The Dupont Merck Pharmaceutical Company	Integrin receptor antagonists
WO1997034876A1 (en)	1996-03-15	1997-09-25	Zeneca Limited	Cinnoline derivatives and use as medicine
DE69709493T2 (de)	1996-06-27	2002-10-31	Pfizer Inc., New York	Substituierte Indazolderivate
CA2264798A1 (en)	1996-09-04	1998-03-12	Pfizer Inc.	Indazole derivatives and their use as inhibitors of phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
ID18494A (id)	1996-10-02	1998-04-16	Novartis Ag	Turunan pirazola leburan dan proses pembuatannya
US6569878B1 (en) *	1997-10-27	2003-05-27	Agouron Pharmaceuticals Inc.	Substituted 4-amino-thiazol-2-yl compounds as cyclin-dependent kinase inhibitors
US6391872B1 (en)	1997-11-04	2002-05-21	Pfizer Inc	Indazole bioisostere replacement of catechol in therapeutically active compounds
US6716978B2 (en)	1997-11-04	2004-04-06	Pfizer Inc	Therapeutically active compounds based on indazole bioisostere replacement of catechol in PDE4 inhibitors
US6040321A (en) *	1997-11-12	2000-03-21	Bristol-Myers Squibb Company	Aminothiazole inhibitors of cyclin dependent kinases
CA2332325A1 (en) *	1998-06-18	1999-12-23	Bristol-Myers Squibb Company	Carbon substituted aminothiazole inhibitors of cyclin dependent kinases
PL201475B1 (pl)	1998-09-29	2009-04-30	Wyeth Corp	Podstawione 3-cyjanochinoliny jako inhibitory białkowych kinaz tyrozynowych

2000
- 2000-02-06 UA UA2001129215A patent/UA71971C2/uk unknown
- 2000-06-02 EA EA200101268A patent/EA200101268A1/ru unknown
- 2000-06-02 PE PE2000000553A patent/PE20010211A1/es not_active Application Discontinuation
- 2000-06-02 NZ NZ514881A patent/NZ514881A/en unknown
- 2000-06-02 CN CN00808440A patent/CN1359380A/zh active Pending
- 2000-06-02 SK SK1730-2001A patent/SK17302001A3/sk unknown
- 2000-06-02 BR BR0011585-1A patent/BR0011585A/pt not_active IP Right Cessation
- 2000-06-02 SV SV2000000096A patent/SV2002000096A/es unknown
- 2000-06-02 IL IL14609400A patent/IL146094A0/xx unknown
- 2000-06-02 WO PCT/US2000/015188 patent/WO2000075120A1/en not_active Ceased
- 2000-06-02 PL PL00352714A patent/PL352714A1/xx not_active Application Discontinuation
- 2000-06-02 AT AT00942660T patent/ATE288424T1/de not_active IP Right Cessation
- 2000-06-02 DE DE60017894T patent/DE60017894T2/de not_active Expired - Fee Related
- 2000-06-02 CZ CZ20014213A patent/CZ20014213A3/cs unknown
- 2000-06-02 HR HR20020008A patent/HRP20020008A2/hr not_active Application Discontinuation
- 2000-06-02 EP EP00942660A patent/EP1181283B1/en not_active Expired - Lifetime
- 2000-06-02 OA OA1200100321A patent/OA11959A/en unknown
- 2000-06-02 EE EEP200100659A patent/EE200100659A/xx unknown
- 2000-06-02 HU HU0202897A patent/HUP0202897A3/hu unknown
- 2000-06-02 CA CA002371158A patent/CA2371158A1/en not_active Abandoned
- 2000-06-02 MX MXPA01012483A patent/MXPA01012483A/es not_active Application Discontinuation
- 2000-06-02 AU AU57254/00A patent/AU778071B2/en not_active Ceased
- 2000-06-02 ES ES00942660T patent/ES2234628T3/es not_active Expired - Lifetime
- 2000-06-02 AP APAP/P/2001/002341A patent/AP2001002341A0/en unknown
- 2000-06-02 KR KR1020017015384A patent/KR20020015333A/ko not_active Withdrawn
- 2000-06-02 UY UY26190A patent/UY26190A1/es not_active Application Discontinuation
- 2000-06-02 JP JP2001501601A patent/JP2003501420A/ja not_active Abandoned
- 2000-06-02 YU YU85601A patent/YU85601A/sh unknown
2001
- 2001-02-15 US US09/783,584 patent/US6620828B2/en not_active Expired - Fee Related
- 2001-10-09 ZA ZA200108291A patent/ZA200108291B/xx unknown
- 2001-10-17 NO NO20015045A patent/NO20015045L/no not_active Application Discontinuation
- 2001-11-29 IS IS6183A patent/IS6183A/is unknown
2002
- 2002-01-02 MA MA26465A patent/MA25530A1/fr unknown
- 2002-01-03 BG BG106276A patent/BG106276A/bg unknown

Also Published As

Publication number	Publication date
AU778071B2 (en)	2004-11-11
US6620828B2 (en)	2003-09-16
EP1181283A1 (en)	2002-02-27
ATE288424T1 (de)	2005-02-15
CZ20014213A3 (cs)	2002-04-17
SV2002000096A (es)	2002-06-07
WO2000075120A1 (en)	2000-12-14
UA71971C2 (en)	2005-01-17
ES2234628T3 (es)	2005-07-01
AP2001002341A0 (en)	2001-12-31
US20020025976A1 (en)	2002-02-28
MA25530A1 (fr)	2002-10-01
CA2371158A1 (en)	2000-12-14
PL352714A1 (en)	2003-09-08
KR20020015333A (ko)	2002-02-27
EE200100659A (et)	2003-02-17
JP2003501420A (ja)	2003-01-14
NO20015045L (no)	2002-02-04
EA200101268A1 (ru)	2002-06-27
BR0011585A (pt)	2002-03-19
DE60017894T2 (de)	2005-12-29
BG106276A (bg)	2002-10-31
HUP0202897A3 (en)	2004-12-28
HUP0202897A2 (hu)	2002-12-28
HRP20020008A2 (en)	2004-02-29
NZ514881A (en)	2003-10-31
MXPA01012483A (es)	2002-07-30
CN1359380A (zh)	2002-07-17
OA11959A (en)	2006-04-17
YU85601A (sh)	2004-09-03
EP1181283B1 (en)	2005-02-02
NO20015045D0 (no)	2001-10-17
IL146094A0 (en)	2002-07-25
UY26190A1 (es)	2000-12-29
ZA200108291B (en)	2002-12-24
PE20010211A1 (es)	2001-03-16
SK17302001A3 (sk)	2004-01-08
AU5725400A (en)	2000-12-28
DE60017894D1 (de)	2005-03-10

Publication	Publication Date	Title
IS6183A (is)	2001-11-29	Díamínóþíazol og notagildi þeirra til að hindra prótín kínasa
IS6411A (is)	2002-06-06	Kaspasa tálmar og notkun þeirra
IS5928A (is)	2001-04-27	Aðferðir og samsetningar til að hindra lyfjaþol
PT1157023E (pt)	2004-03-31	Epotilonas modificadas em c-21
NO20001323D0 (no)	2000-03-14	Dipeptid-apoptose inhibitorer og deres anvendelse
DK1354888T3 (da)	2009-09-21	Glukopyranosyloxypyrazolderivater og anvendelse deraf i medikamenter
PL375447A1 (en)	2005-11-28	Protein kinase inhibitors and uses thereof
IS6385A (is)	2002-05-15	Ný notkun og nýjar N-asabísýkló-amíð afleiður
AU2728201A (en)	2001-07-03	4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors
IL154016A0 (en)	2003-07-31	Pyrazole derivatives and their use as protein kinase inhibitors
NO20004223L (no)	2001-02-26	Fremgangsmåter og blandinger for sementering i kalde omgivelser (kaldt miljö)
NO991150D0 (no)	1999-03-10	Pyrazolopyrimidiner og pyrazolotriaziner
NO20021449D0 (no)	2002-03-22	Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og anvendelse derav
AU2001270260A1 (en)	2002-01-14	4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors
NO20005692L (no)	2001-01-10	Forbedringer i og vedrörende bygningselementer, og fremgangsmåter vedrörende samme
NO20013745L (no)	2001-09-28	Ventiler for bruk i brönner
DK1263745T3 (da)	2004-08-16	Substituerede 3-phenyl-5-alkoxy-1,3,4-oxadiaxol-2-oner og anvendelse deraf til inhibering af hormonfölsom lipase
IS6096A (is)	2001-09-28	Latar fyrir LFA-1 bindingu við ICAM og notkun á þeim
NO20021305D0 (no)	2002-03-15	DNA-konstruksjon og dens anvendelse
NO20013085D0 (no)	2001-06-21	Fosfororganiske forbindelser og deres anvendelse
FI19991928L (fi)	2001-03-10	Punnitusmenetelmä ja -järjestely
NO20014946D0 (no)	2001-10-11	Strukturerte flerbrukspakninger og deres anvendelse
NO992310D0 (no)	1999-05-12	Inhibitorer og deres anvendelse i oljer
NO20005727L (no)	2001-01-15	Polymerprodukter og deres anvendelse i olje
DK200000225U4 (da)	2001-10-26	Ophængningssystem og anvendelse deraf